Rajiv D Machado1, Richard C Trembath2,3, Laura Southgate4,2, Maja Sukalo5, Anastasios S V Karountzos1, Edward J Taylor1, Claire S Collinson4, Deborah Ruddy3, Katie M Snape6, Bruno Dallapiccola7, John L Tolmie8, Shelagh Joss8, Francesco Brancati9, M Cristina Digilio10, Luitgard M Graul-Neumann11, Leonardo Salviati12, Wiltrud Coerdt13, Emmanuel Jacquemin14,15, Wim Wuyts16, Martin Zenker5. 1. School of Life Sciences, University of Lincoln, Lincoln, United Kingdom. 2. Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London, United Kingdom. 3. Department of Clinical Genetics, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. 4. Division of Genetics & Molecular Medicine, King's College London, Faculty of Life Sciences & Medicine, Guy's Hospital, London, United Kingdom. 5. Institute of Human Genetics, Otto-von-Guericke-Universität Magdeburg, University Hospital Magdeburg, Magdeburg, Germany. 6. Department of Clinical Genetics, South West Thames Regional Genetics Service, St George's Healthcare NHS Trust, London, United Kingdom. 7. Scientific Directorate, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. 8. South West of Scotland Clinical Genetics Service, Southern General Hospital, Glasgow, United Kingdom. 9. Department of Medical, Oral & Biotechnological Sciences, Gabriele d'Annunzio University of Chieti-Pescara, Chieti, Italy. 10. Medical Genetics, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. 11. Ambulantes Gesundheitszentrum der Charité-Universitätsmedizin Berlin, Berlin, Germany. 12. Clinical Genetics Unit, Department of Woman & Child Health, University of Padova, Padova, Italy. 13. Institute of Human Genetics, Mainz University Medical Center, Mainz, Germany. 14. Pediatric Hepatology & Liver Transplantation Unit, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Hepatinov, Le Kremlin Bicêtre, France. 15. Inserm U1174, University Paris-Sud 11, Orsay, France. 16. Department of Medical Genetics, University & University Hospital of Antwerp, Edegem, Belgium.
Abstract
BACKGROUND: Adams-Oliver syndrome (AOS) is a rare disorder characterized by congenital limb defects and scalp cutis aplasia. In a proportion of cases, notable cardiac involvement is also apparent. Despite recent advances in the understanding of the genetic basis of AOS, for the majority of affected subjects, the underlying molecular defect remains unresolved. This study aimed to identify novel genetic determinants of AOS. METHODS AND RESULTS: Whole-exome sequencing was performed for 12 probands, each with a clinical diagnosis of AOS. Analyses led to the identification of novel heterozygous truncating NOTCH1 mutations (c.1649dupA and c.6049_6050delTC) in 2 kindreds in which AOS was segregating as an autosomal dominant trait. Screening a cohort of 52 unrelated AOS subjects, we detected 8 additional unique NOTCH1 mutations, including 3 de novo amino acid substitutions, all within the ligand-binding domain. Congenital heart anomalies were noted in 47% (8/17) of NOTCH1-positive probands and affected family members. In leukocyte-derived RNA from subjects harboring NOTCH1 extracellular domain mutations, we observed significant reduction of NOTCH1 expression, suggesting instability and degradation of mutant mRNA transcripts by the cellular machinery. Transient transfection of mutagenized NOTCH1 missense constructs also revealed significant reduction in gene expression. Mutant NOTCH1 expression was associated with downregulation of the Notch target genes HEY1 and HES1, indicating that NOTCH1-related AOS arises through dysregulation of the Notch signaling pathway. CONCLUSIONS: These findings highlight a key role for NOTCH1 across a range of developmental anomalies that include cardiac defects and implicate NOTCH1 haploinsufficiency as a likely molecular mechanism for this group of disorders.
BACKGROUND: Adams-Oliver syndrome (AOS) is a rare disorder characterized by congenital limb defects and scalp cutis aplasia. In a proportion of cases, notable cardiac involvement is also apparent. Despite recent advances in the understanding of the genetic basis of AOS, for the majority of affected subjects, the underlying molecular defect remains unresolved. This study aimed to identify novel genetic determinants of AOS. METHODS AND RESULTS: Whole-exome sequencing was performed for 12 probands, each with a clinical diagnosis of AOS. Analyses led to the identification of novel heterozygous truncating NOTCH1 mutations (c.1649dupA and c.6049_6050delTC) in 2 kindreds in which AOS was segregating as an autosomal dominant trait. Screening a cohort of 52 unrelated AOS subjects, we detected 8 additional unique NOTCH1 mutations, including 3 de novo amino acid substitutions, all within the ligand-binding domain. Congenital heart anomalies were noted in 47% (8/17) of NOTCH1-positive probands and affected family members. In leukocyte-derived RNA from subjects harboring NOTCH1 extracellular domain mutations, we observed significant reduction of NOTCH1 expression, suggesting instability and degradation of mutant mRNA transcripts by the cellular machinery. Transient transfection of mutagenized NOTCH1 missense constructs also revealed significant reduction in gene expression. Mutant NOTCH1 expression was associated with downregulation of the Notch target genes HEY1 and HES1, indicating that NOTCH1-related AOS arises through dysregulation of the Notch signaling pathway. CONCLUSIONS: These findings highlight a key role for NOTCH1 across a range of developmental anomalies that include cardiac defects and implicate NOTCH1 haploinsufficiency as a likely molecular mechanism for this group of disorders.
Authors: Claudia Algaze; Edward D Esplin; Alexander Lowenthal; Louanne Hudgins; Theresa Ann Tacy; Elif Seda Selamet Tierney Journal: Am J Med Genet A Date: 2013-04-23 Impact factor: 2.802
Authors: Laura Southgate; Rajiv D Machado; Katie M Snape; Martin Primeau; Dimitra Dafou; Deborah M Ruddy; Peter A Branney; Malcolm Fisher; Grace J Lee; Michael A Simpson; Yi He; Teisha Y Bradshaw; Bettina Blaumeiser; William S Winship; Willie Reardon; Eamonn R Maher; David R FitzPatrick; Wim Wuyts; Martin Zenker; Nathalie Lamarche-Vane; Richard C Trembath Journal: Am J Hum Genet Date: 2011-05-13 Impact factor: 11.025
Authors: Joshua F Alfaro; Cheng-Xin Gong; Matthew E Monroe; Joshua T Aldrich; Therese R W Clauss; Samuel O Purvine; Zihao Wang; David G Camp; Jeffrey Shabanowitz; Pamela Stanley; Gerald W Hart; Donald F Hunt; Feng Yang; Richard D Smith Journal: Proc Natl Acad Sci U S A Date: 2012-04-19 Impact factor: 11.205
Authors: Ranad Shaheen; Mona Aglan; Kim Keppler-Noreuil; Eissa Faqeih; Shinu Ansari; Kim Horton; Adel Ashour; Maha S Zaki; Fatema Al-Zahrani; Anna M Cueto-González; Ghada Abdel-Salam; Samia Temtamy; Fowzan S Alkuraya Journal: Am J Hum Genet Date: 2013-03-21 Impact factor: 11.025
Authors: Susan J Hassed; Graham B Wiley; Shaofeng Wang; Ji-Yun Lee; Shibo Li; Weihong Xu; Zhizhuang J Zhao; John J Mulvihill; James Robertson; James Warner; Patrick M Gaffney Journal: Am J Hum Genet Date: 2012-08-10 Impact factor: 11.025
Authors: Emmi Helle; Aldo Córdova-Palomera; Tiina Ojala; Priyanka Saha; Praneetha Potiny; Stefan Gustafsson; Erik Ingelsson; Michael Bamshad; Deborah Nickerson; Jessica X Chong; Euan Ashley; James R Priest Journal: Genet Epidemiol Date: 2018-12-04 Impact factor: 2.135
Authors: Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell Journal: Circulation Date: 2018-11-20 Impact factor: 29.690
Authors: Josephina A N Meester; Laura Southgate; Anna-Barbara Stittrich; Hanka Venselaar; Sander J A Beekmans; Nicolette den Hollander; Emilia K Bijlsma; Appolonia Helderman-van den Enden; Joke B G M Verheij; Gustavo Glusman; Jared C Roach; Anna Lehman; Millan S Patel; Bert B A de Vries; Claudia Ruivenkamp; Peter Itin; Katrina Prescott; Sheila Clarke; Richard Trembath; Martin Zenker; Maja Sukalo; Lut Van Laer; Bart Loeys; Wim Wuyts Journal: Am J Hum Genet Date: 2015-08-20 Impact factor: 11.025